NEW YORK, June 29 – MDS Proteomics will to identify up to 150 proteins as drug targets in a collaboration with antibody-based pharmaceutical company Abgenix, and in return Abgenix has agreed to make a $15 million equity investment in MDS Proteomics, the companies said Friday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.